STOCK TITAN

The Beachbody Company, Inc. (BODI) Financials

BODI
Trailing 12 months to June 30, 2026
Revenue $219.3M -32.5% YoY
Net Income $12.5M +121.4% YoY
EPS (Diluted) $1.67 +119.6% YoY
Free Cash Flow $7.6M +338.0% YoY
Market Cap $34.3M as of Oct 10, 2026
Price / Sales 0.2x on $219.3M revenue, trailing 12 months to June 30, 2026
Price / Earnings 2.8x on $12.5M net income, trailing 12 months to June 30, 2026
Price / Book 0.9x on $37.2M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 10, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BODI SEC filings page.

The Beachbody Company, Inc. (BODI) reported $219.3M in revenue over the twelve months to Jun 30, 2026, down 32.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BODI FY2025

Operating profitability and positive cash flow arrived in FY2025, but revenue continued shrinking and liquidity remained tight.

From FY2024 to FY2025, revenue fell to $251.7M while gross margin expanded to 73.0%, indicating that the improvement came from a leaner or more favorable business mix rather than sales growth. Operating margin then moved from -15.8% to 2.2%, showing that lower operating costs were sufficient to push the smaller revenue base into reported operating profit.

FY2025 operating cash flow was $21.8M even as net income was a loss of $2.9M, so cash generation outpaced accounting earnings. After $4.4M of capital expenditures, free cash flow remained $17.4M, indicating the improvement was not solely an accounting-margin effect.

Current liabilities exceeded current assets in FY2025, leaving limited short-term balance-sheet cushion despite total liabilities falling to $115.7M. Debt-to-equity reached 0.7 from 0.3 in FY2023 as the equity base remained thin, making the ratio sensitive to small balance-sheet changes.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 31 / 100
Financial Health Score 31/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of The Beachbody Company, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
28

The Beachbody Company, Inc. has an operating margin of 2.2%, meaning the company retains $2 of operating profit per $100 of revenue. This below-average margin results in a low score of 28/100, suggesting thin profitability after operating expenses. This is up from -15.8% the prior year.

Growth
2

The Beachbody Company, Inc.'s revenue declined 39.9% year-over-year, from $418.8M to $251.7M. This contraction results in a growth score of 2/100.

Leverage
96

The Beachbody Company, Inc. carries a low D/E ratio of 0.72, meaning only $0.72 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 96/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
9

The Beachbody Company, Inc.'s current ratio of 0.74 is below the typical benchmark, resulting in a score of 9/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
34

The Beachbody Company, Inc. has a free cash flow margin of 6.9%, earning a moderate score of 34/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
17

The Beachbody Company, Inc. posts a -9.1% return on equity (ROE), meaning it loses $9 for every $100 of shareholders' equity. This results in a returns score of 17/100. This is up from -254.3% the prior year.

Altman Z-Score Distress
-4.33

The Beachbody Company, Inc. scores -4.33, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($34.3M) relative to total liabilities ($115.7M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
5/8

The Beachbody Company, Inc. passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed
N/A

The Beachbody Company, Inc. reported a net loss of $2.9M while generating $21.8M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
1.11x

The Beachbody Company, Inc. earns $1.11 in operating income for every $1 of interest expense ($5.5M vs $5.0M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$49.6M
YoY-22.4%
QoQ-8.6%
5Y CAGR-26.0%

The Beachbody Company, Inc. generated $49.6M in revenue in Q2 2026. This represents a decrease of 22.4% from the same quarter a year earlier. Against the prior quarter it is down 8.6%.

EBITDA
$3.6M
YoY+286.1%
QoQ-32.3%

The Beachbody Company, Inc.'s EBITDA was $3.6M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 286.1% from the same quarter a year earlier. Against the prior quarter it is down 32.3%.

Net Income
$1.4M
YoY+123.5%
QoQ-39.5%

The Beachbody Company, Inc. reported $1.4M in net income in Q2 2026. This represents an increase of 123.5% from the same quarter a year earlier. Against the prior quarter it is down 39.5%.

EPS (Diluted)
$0.11

The Beachbody Company, Inc. earned $0.11 per diluted share (EPS) in Q2 2026.

Cash & Balance Sheet

Free Cash Flow
-$4.0M
YoY-265.3%
QoQ-132.3%

The Beachbody Company, Inc. recorded an outflow of $4.0M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 265.3% from the same quarter a year earlier. Against the prior quarter it is down 132.3%.

Cash & Debt
$32.4M
YoY+26.7%
QoQ-11.5%
5Y CAGR-37.8%

The Beachbody Company, Inc. held $32.4M in cash against $21.4M in long-term debt as of Q2 2026.

Shares Outstanding
Diluted avg 8M

The Beachbody Company, Inc. had a weighted average of 8M diluted shares in Q2 2026; the shares outstanding count is not reported for that period.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin
72.0%
YoY-0.3pp
QoQ+0.2pp
5Y change+2.9pp

The Beachbody Company, Inc.'s gross margin was 72.0% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.

Operating Margin
3.4%
YoY+9.6pp
QoQ-2.4pp
5Y change+16.8pp

The Beachbody Company, Inc.'s operating margin was 3.4% in Q2 2026, reflecting core business profitability. This is up 9.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.4 percentage points.

Net Margin
2.8%
YoY+12.0pp
QoQ-1.4pp
5Y change+8.4pp

The Beachbody Company, Inc.'s net profit margin was 2.8% in Q2 2026, showing the share of revenue converted to profit. This is up 12.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.4 percentage points.

Return on Equity
3.7%
YoY+33.0pp
QoQ-2.9pp
5Y change+5.9pp

The Beachbody Company, Inc.'s ROE was 3.7% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 33.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.9 percentage points.

Capital Allocation

Capital Expenditures
$760K
YoY-58.2%
QoQ+11.1%
5Y CAGR-44.1%

The Beachbody Company, Inc. invested $760K in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 58.2% from the same quarter a year earlier. Against the prior quarter it is up 11.1%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

BODI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BODI quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$49.6M-22.4%$54.3M-25.0%$55.5M-35.7%$59.9M-41.4%$63.9M-42.0%$72.4M-39.7%$86.4M-27.4%$102.2M-20.3%
Cost of Revenue$13.9M-21.7%$15.3M-26.6%$14.2M-44.4%$15.2M-54.4%$17.7M-47.6%$20.8M-46.3%$25.5M-43.4%$33.4M-37.3%
Gross Profit$35.7M-22.7%$39.0M-24.3%$41.3M-32.1%$44.6M-35.1%$46.2M-39.5%$51.5M-36.6%$60.9M-17.7%$68.8M-8.3%
SG&A Expenses$8.6M-26.0%$7.7M-33.8%$6.5M-43.4%$10.1M-13.8%$11.6M-6.6%$11.7M-13.5%$11.6M-14.8%$11.8M-20.3%
Operating Income$1.7M+142.1%$3.1M+184.8%$8.2M+124.9%$5.0M+138.3%-$4.0M+58.2%-$3.7M+66.1%-$32.9M+45.5%-$13.0M+55.1%
EBITDA$3.6M+286.1%$5.3M+779.6%$10.1M+149.8%$6.9M+236.1%-$1.9M+52.3%-$786K+85.6%-$20.2M+59.3%-$5.0M+75.4%
Interest Expense$1.0M-20.4%$1.0M-35.2%$1.1M-36.4%$1.1M-35.8%$1.3M-23.2%$1.6M-16.5%$1.7M-18.7%$1.6M-20.6%
Income Tax$118K+16.8%$32K-28.9%$28K+660.0%-$49K-142.6%$101K+50.7%$45K-27.4%-$5K+91.9%$115K+82.5%
Net Income$1.4M+123.5%$2.3M+139.8%$5.2M+115.1%$3.6M+129.7%-$5.9M+45.7%-$5.7M+59.6%-$34.6M+46.9%-$12.0M+63.3%
EPS (Basic)$0.19+122.4%$0.32+138.1%$0.75+114.8%$0.51+129.1%-$0.85+46.5%-$0.84+60.0%-$5.06+79.1%-$1.75+66.9%
EPS (Diluted)$0.11$0.30+135.7%$0.75+114.8%$0.51+129.1%-$0.85+46.5%-$0.84+60.0%-$5.06-$1.75+66.9%
Diluted Shares (Avg)8M8M+10.0%N/A7M+3.0%7M+2.0%7M+1.8%N/A7M+10.7%

Not reported in any period shown, so not listed: R&D Expenses.

BODI Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BODI quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$136.5M-6.4%$143.1M-6.2%$147.0M-15.8%$146.4M-35.1%$145.9M-40.4%$152.5M-42.0%$174.6M-36.9%$225.5M-35.1%
Current Assets$57.4M+0.2%$61.6M-0.1%$63.8M-18.9%$60.4M-36.6%$57.3M-44.6%$61.7M-47.0%$78.7M-34.0%$95.3M-27.1%
Cash & Equivalents$32.4M+26.7%$36.6M+101.9%$39.0M+93.3%$33.9M+5.1%$25.6M-20.9%$18.1M-53.4%$20.2M-39.6%$32.3M-15.4%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$12.6M+10.2%$10.1M-24.9%$9.4M-42.3%$11.1M-38.1%$11.4M-52.0%$13.5M-35.2%$16.3M-34.7%$18.0M-43.3%
Accounts Receivable$1.3M-27.3%$1.5M-24.3%$1.1M-21.5%$1.5M-13.9%$1.9M+5.7%$1.9M+19.8%$1.4M+14.1%$1.7M+13.8%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$65.2M0.0%$65.2M0.0%$65.2M0.0%$65.2M-23.5%$65.2M-23.5%$65.2M-23.5%$65.2M-23.5%$85.2M-32.0%
Total Liabilities$99.3M-21.0%$108.8M-15.3%$115.7M-21.0%$121.7M-27.2%$125.7M-29.4%$128.5M-32.5%$146.4M-24.6%$167.1M-19.0%
Current Liabilities$73.0M-24.1%$80.8M-32.0%$86.6M-32.2%$93.1M-37.4%$96.1M-34.4%$118.8M-26.9%$127.6M-22.7%$148.6M-14.0%
Non-Current Liabilities$26.3M-11.0%$27.9M+189.2%$29.1M+55.3%$28.6M+55.1%$29.6M-6.4%$9.7M-65.0%$18.7M-35.1%$18.5M-44.8%
Long-Term Debt$21.4M-8.0%$22.0M$22.6M+133.4%$22.9M+128.9%$23.3M+20.9%$0-100.0%$9.7M-55.0%$10.0M-63.9%
Total Equity$37.2M+84.5%$34.4M+42.9%$31.3M+11.2%$24.7M-57.7%$20.2M-69.8%$24.0M-67.0%$28.2M-66.0%$58.4M-58.6%
Retained Earnings-$642.7M+1.9%-$644.1M+0.8%-$646.4M-0.4%-$651.6M-7.0%-$655.2M-9.8%-$649.3M-10.8%-$643.5M-12.5%-$609.0M-20.1%

BODI Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BODI quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow-$3.2M-176.5%-$1.0M-144.4%$5.0M+174.1%$10.2M+841.5%$4.2M+558.2%$2.3M-74.4%-$6.7M+15.4%$1.1M+600.9%
Depreciation & Amortization$1.9M-3.8%$2.2M-22.9%$1.9M-85.1%$1.9M-76.4%$2.0M-62.6%$2.9M-46.3%$12.7M+55.1%$8.0M-6.1%
Stock-Based Compensation$1.3M-36.2%$1.1M-35.2%N/A$1.0M-72.1%$2.0M-57.5%$1.7M-60.5%N/A$3.6M-44.2%
Capital Expenditures$760K-58.2%$684K-1.4%$701K+23.4%$1.2M+15.4%$1.8M+45.8%$694K-59.2%$568K-47.3%$1.0M+119.4%
Free Cash Flow-$4.0M-265.3%-$1.7M-204.6%$4.3M+158.7%$9.0M+16881.1%$2.4M+211.5%$1.6M-77.8%-$7.3M+19.2%$53K+107.7%
Investing Cash Flow-$760K+58.2%-$684K+1.4%-$701K-23.4%-$1.2M-15.4%-$1.8M-45.8%-$694K-117.8%-$568K+47.3%-$1.0M+78.2%
Financing Cash Flow-$32K-100.7%-$608K+83.7%$519K+112.8%-$274K+10.5%$4.5M+205.3%-$3.7M+48.3%-$4.1M-201.2%-$306K+98.0%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

BODI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BODI quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Gross Margin72.0%-0.3pp71.8%+0.6pp74.5%+4.0pp74.6%+7.2pp72.3%+3.0pp71.2%+3.5pp70.5%+8.3pp67.3%+8.8pp
Operating Margin3.4%+9.6pp5.7%+10.8pp14.7%+52.8pp8.3%+21.1pp-6.2%+2.4pp-5.1%+3.9pp-38.1%+12.6pp-12.7%+9.9pp
Net Margin2.8%+12.0pp4.2%+12.2pp9.4%+49.4pp6.0%+17.7pp-9.2%+0.6pp-7.9%+3.9pp-40.0%+14.6pp-11.8%+13.7pp
Return on Equity3.7%+33.0pp6.7%+30.6pp16.7%+139.3pp14.5%+35.0pp-29.3%-13.0pp-23.9%-4.4pp-122.7%-44.1pp-20.6%+2.6pp
Return on Assets1.0%+5.0pp1.6%+5.4pp3.5%+23.4pp2.4%+7.8pp-4.0%+0.4pp-3.8%+1.6pp-19.8%+3.7pp-5.3%+4.1pp
Current Ratio0.79+0.2x0.76+0.2x0.74+0.1x0.650.0x0.60-0.1x0.52-0.2x0.62-0.1x0.64-0.1x
Debt-to-Equity0.58-0.6x0.64+0.6x0.72+0.4x0.93+0.8x1.16+0.9x0.00-0.3x0.34+0.1x0.170.0x
Asset Turnover0.36-0.1x0.38-0.1x0.38-0.1x0.410.0x0.440.0x0.470.0x0.49+0.1x0.45+0.1x
FCF Margin-8.1%-11.9pp-3.2%-5.5pp7.7%+16.2pp15.0%+15.0pp3.8%+5.8pp2.3%-3.9pp-8.5%-0.9pp0.1%+0.6pp

Note: The current ratio is below 1.0 (0.74), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
The Beachbody Company, Inc. BODI FY2025 $251.7M -$2.9M -1.1% $34.3M 31/100
Zedge, Inc. ZDGE FY2025 $29.4M -$2.4M -8.1% $46.0M 35/100
PodcastOne, Inc. PODC FY2026 $61.7M -$2.6M -4.3% $66.3M 38/100
Scienjoy Holding Corporation SJ FY2025 $177.5M -$84.0M -47.3% $36.5M 44/100
Giftify, Inc. GIFT FY2025 $83.2M -$10.5M -12.6% $20.4M 31/100
comScore, Inc. SCOR FY2025 $357.5M -$10.0M -2.8% $61.6M 33/100

Frequently Asked Questions

What is The Beachbody Company, Inc.'s annual revenue?

The Beachbody Company, Inc. (BODI) reported $251.7M in total revenue for fiscal year 2025. This represents a -39.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is The Beachbody Company, Inc.'s revenue growing?

The Beachbody Company, Inc. (BODI) revenue declined by 39.9% year-over-year, from $418.8M to $251.7M in fiscal year 2025.

Is The Beachbody Company, Inc. profitable?

No, The Beachbody Company, Inc. (BODI) reported a net income of -$2.9M in fiscal year 2025, with a net profit margin of -1.1%.

The Beachbody Company, Inc. (BODI) reported diluted earnings per share of -$0.41 for fiscal year 2025. This represents a 96.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

The Beachbody Company, Inc. (BODI) had EBITDA of $14.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, The Beachbody Company, Inc. (BODI) had $39.0M in cash and equivalents against $22.6M in long-term debt.

The Beachbody Company, Inc. (BODI) had a gross margin of 73.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

The Beachbody Company, Inc. (BODI) had an operating margin of 2.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

The Beachbody Company, Inc. (BODI) had a net profit margin of -1.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

The Beachbody Company, Inc. (BODI) has a return on equity of -9.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

The Beachbody Company, Inc. (BODI) generated $17.4M in free cash flow during fiscal year 2025. This represents a 976.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

The Beachbody Company, Inc. (BODI) generated $21.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

The Beachbody Company, Inc. (BODI) had $147.0M in total assets as of fiscal year 2025, including both current and long-term assets.

The Beachbody Company, Inc. (BODI) invested $4.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

The Beachbody Company, Inc. (BODI) invested $1.7M in research and development during fiscal year 2025.

The Beachbody Company, Inc. (BODI) had a current ratio of 0.74 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

The Beachbody Company, Inc. (BODI) had a debt-to-equity ratio of 0.72 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

The Beachbody Company, Inc. (BODI) had a return on assets of -1.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

The Beachbody Company, Inc. (BODI) trades at 2.8x earnings, its market capitalization divided by net income of $12.5M net income, trailing 12 months to June 30, 2026. The market capitalization is $34.3M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

The Beachbody Company, Inc. (BODI) trades at 0.2x sales, its market capitalization divided by revenue of $219.3M revenue, trailing 12 months to June 30, 2026. The market capitalization is $34.3M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

The Beachbody Company, Inc. (BODI) has an Altman Z-Score of -4.33, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

The Beachbody Company, Inc. (BODI) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

The Beachbody Company, Inc. (BODI) reported a net loss of $2.9M while generating $21.8M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

The Beachbody Company, Inc. (BODI) has an interest coverage ratio of 1.11x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

The Beachbody Company, Inc. (BODI) scores 31 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top